Delivery Order SPE2DB20D3103-SPE2DB22FM0K8
Award Date 12/20/21
Potential Completion Date 12/21/21
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Feraheme (ferumoxytol) 510 mg/17 mL vials. The $2,891.97 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which enables the efficient procurement of a wide range of pharmaceutical products and medical supplies to support...
- This federal contract award is for the delivery of Feraheme (ferumoxytol) 510 mg/17 mL vials to the Defense Logistics Agency (DLA). The $3,913.10 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 23, 2021, with an ultimate completion date of August 24, 2021. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,078.98, is for the delivery of Feraheme, a 510 mg/17 ml iron replacement medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 11, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme 510 mg/17 ml vials. The contract, valued at $23,382.46, is a delivery order with a firm-fixed price pricing type. The award has an ultimate completion date of June 9, 2022. This contract is a Child contract associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The $17,401.17 delivery order is for the pharmaceutical product Feraheme, a 510 mg/17 ml injectable iron replacement medication. The contract is a firm-fixed-price delivery order with a performance period ending on March 28, 2022. This contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $7,547.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, covers the procurement of Feraheme 510 mg/17 ml vials. There was no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $2,895.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the pharmaceutical product Feraheme 510 mg/17 ml vial, with a performance period extending through May 7, 2025. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Feraheme 510 mg/17 mL vials, a critical medication used in the treatment of anemia. The contract, valued at $13,118.20, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 27, 2024. This contract is not associated with any set-aside program. As a large pharmaceutical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Feraheme 510 mg/17 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $54,916.16 and a performance period extending to July 7, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme 510 mg/17 ml vials. The contract has a firm fixed-price structure and a ceiling value of $9,635.91. It was awarded on November 4, 2024, with an ultimate completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...